GLP-1 TirzepatideRx

All-in monthly price at 10 mg — medication plus any membership fee

Home Guides Zepbound vs Mounjaro vs Compounded

Zepbound vs Mounjaro vs Compounded: Same Molecule, Three Prices

Zepbound and Mounjaro are the identical molecule from the identical manufacturer at identical strengths. The difference is the FDA label — Mounjaro for type 2 diabetes, Zepbound for chronic …

10 mg

Short answer

Zepbound and Mounjaro are the identical molecule from the identical manufacturer at identical strengths. The difference is the FDA label — Mounjaro for type 2 diabetes, Zepbound for chronic weight management and for moderate-to-severe obstructive sleep apnea with obesity. Compounded tirzepatide is the same active ingredient from a licensed pharmacy without FDA approval.

Why the label determines your price

Insurance decisions follow indications. With a type 2 diabetes diagnosis, Mounjaro is on-label and the Mounjaro savings card can bring commercially insured patients to about $25 per month. Without diabetes, Mounjaro is off-label and will not be covered, and Zepbound is the correct prescription.

This is not a loophole to exploit — it is a reason to check which diagnoses you already carry before you assume you are a cash-pay patient.

The three-way cost picture

Retail Zepbound sits around $1,089 per month. LillyDirect self-pay vials run roughly $299–$449 depending on strength. Compounded tirzepatide runs roughly $99–$299. Same molecule at every tier; what differs is FDA review, packaging, and who carries the quality-assurance burden.

What you give up going compounded

FDA does not review compounded products for safety, effectiveness or quality. You are relying on the compounding pharmacy's own standards and your state board's oversight. For many people that trade is worth $700 a month; for some it is not. It should be an informed choice rather than a default.

Price your actual dose

Six dose tiers, sixteen tracked programs, twelve-month totals.

Open the calculator

Common questions

Is compounded tirzepatide legal in 2026?

Yes, when a state-licensed 503A pharmacy prepares it for an identified individual patient with a valid prescription. FDA declared the tirzepatide shortage resolved in December 2024, which ended mass compounding under shortage rules. Patient-specific compounding under section 503A of the Federal Food, Drug, and Cosmetic Act continues.

Can I use HSA or FSA funds for tirzepatide?

Generally yes for prescribed weight-management medication, including compounded products, though some plan administrators require a letter of medical necessity. Confirm with your administrator and keep every receipt.

How long does it take to see results on tirzepatide?

Appetite change usually arrives within the first one to two weeks, often before the scale moves. Meaningful weight loss typically becomes visible between weeks 4 and 12, with the steepest part of the curve between months 3 and 9. Trial weight loss continued accumulating through week 72.

Does insurance cover tirzepatide?

It depends on your plan and your diagnosis. Many commercial plans exclude weight-management drugs entirely. Zepbound carries a specific FDA indication for moderate-to-severe obstructive sleep apnea with obesity, and plans that exclude weight loss often cover a diagnosed sleep disorder. With type 2 diabetes, Mounjaro is on-label.

People also ask about tirzepatide vs zepbound mounjaro

What is tirzepatide vs zepbound mounjaro?

Tirzepatide vs zepbound mounjaro is covered in full on this page, with the clinical detail drawn from the tirzepatide prescribing information and the published SURMOUNT and SURPASS trial program, and any price figures drawn from our tracked dataset and dated to their last verification.

Does tirzepatide vs zepbound mounjaro apply to compounded tirzepatide as well as Zepbound?

The molecule is the same, so the clinical content applies to both. What differs is regulatory status, dose metering and price: compounded preparations are not FDA-approved, arrive as a multi-dose vial you measure yourself, and cost a fraction of the brand routes.

How much does tirzepatide vs zepbound mounjaro cost per month in 2026?

Compounded tirzepatide runs from $133 per month at the entry dose across the 21 compounded programs we track. At a 10 mg maintenance dose the cheapest tracked route is Oak Longevity at $199 per month, or about $2,388 for a first year on the standard escalation. Brand Zepbound through manufacturer self-pay sits well above that and pharmacy retail well above again. Verified 2026-08-05.

Is tirzepatide vs zepbound mounjaro FDA-approved?

Brand tirzepatide (Zepbound and Mounjaro) is FDA-approved. Compounded tirzepatide is not: FDA does not approve compounded drugs and does not review them for safety, effectiveness or quality before they are marketed. The active molecule is the same; the regulatory review is not.

Primary sources

Clinical, dosing and regulatory statements on this page rest on the documents below. Links go to the publisher, not to a summary of it. Prices are not sourced here — they carry a verification date instead, and the reason is set out in the source ledger.

  1. ZEPBOUND (tirzepatide) full prescribing information — DailyMed, US National Library of Medicine. Dose ladder, contraindications, warnings, storage.
  2. FDA’s concerns with unapproved GLP-1 drugs used for weight loss — US Food and Drug Administration. Compounded GLP-1 risks, API import alert, cold-chain complaints.
  3. FD&C Act provisions that apply to human drug compounding — US Food and Drug Administration. Why a compounded preparation is lawful without being FDA-approved.
  4. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) — N Engl J Med 2022;387:205-216. Registration NCT04184622. The weight-reduction and adverse-event figures used across this site.
  5. The full source ledger — every primary source, what it supports, the date we read it, and the claims we deliberately do not source.